why choose us

First received: June 05, 2023

Clinical Trial: Locoregional Administration of TIL and Lymphodepletion in Patients With Melanoma and Liver Metastases

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Uveal Melanoma

Study Type: INTERVENTIONAL


Official Title: Hepatic Arterial Infusion of Autologous Tumor Infiltrating Lymphocytes Preconditioned With Percutaneous Hepatic Perfusion With Melphalan in Patients With Melanoma and Liver Metastases

Brief Summary: Evaluate the safety and tolerability of treatment with autologous tumor infiltrating lymphocytes (TIL) administered via hepatic arterial infusion and preconditioning with percutaneous hepatic perfusion in patients with liver metastases (but not restricted to) of malignant melanoma

Read more